StockData
Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc. (RLMD) stock

RLMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$4.16−0.27 (-6.09%)

Close on Nov 12, 2026Market cap $443.75MP/E –Yield –

Relmada Therapeutics statistics

60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Nov 12, 2026 (estimated, during market hours)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$443.75M
$280.48M
Enterprise Value
$241.62M
$148.62M
PB Ratio
2.29
2.05
P/TBV Ratio
2.29
2.29

Share statisticsIndustry

Shares Change (YoY)
193.4%
10.9%
Shares Change (QoQ)
0.02%
0.48%
Float
103M
49M
Shares Held by Insiders
3.27%
12.1%
Shares Held by Institutions
94.0%
56.4%

Short sellingIndustry

Short Interest
11M
–
Short Interest Change
-11.0%
-0.76%
Short % of Float
10.5%
9.06%
Short % of Shares Outstanding
10.2%
6.30%
Days to Cover
6.36
5.13

Stock price statisticsIndustry

52-Week High
$8.00
–
52-Week Low
$3.07
–
20-Day Moving Average
$3.66
–
50-Day Moving Average
$3.77
–
200-Day Moving Average
$5.37
–
Average True Range (14)
$0.28
–
Price Change (1 Week)
10.3%
1.51%
Price Change (1 Month)
28.4%
-2.37%
Price Change (3 Months)
-13.3%
-21.1%
Price Change (6 Months)
-43.9%
-22.8%
Price Change (YTD)
-13.9%
-22.6%
Price Change (1 Year)
26.4%
-21.0%
Price Change (3 Years)
47.5%
-24.8%
Price Change (5 Years)
-81.8%
-76.9%
Price Change (10 Years)
15.6%
-63.2%
Average Volume (10 Days)
2M
–
Average Volume (20 Days)
2M
–
Average Volume (90 Days)
1M
–
Relative Volume
0.73
0.80
Relative Strength Index (14)
58.3
44.7
Volatility (1 Year)
92.9%
80.2%
Beta (5 Years)
1.35
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-64.7%
-51.3%
Return on Assets (ROA)
-59.7%
-40.7%
Return on Capital Employed (ROCE)
-34.4%
-38.1%

Financial positionIndustry

Current Ratio
26.37
3.31
Quick Ratio
25.99
2.41

EfficiencyIndustry

Profits Per Employee
-$3.86M
-$683.67K
Employee Count
17
75
WACC
11.6%
10.0%

Income statement (TTM)Industry

Operating Income
-$67.90M
-$20.99M
Net Income
-$65.70M
-$21.61M
EBITDA
-$67.90M
-$16.85M
EPS (Diluted)
-$0.78
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$202.12M
$16.98M
Net Cash Per Share
$1.89
$0.72
Equity (Book Value)
$193.74M
$52.68M
Book Value Per Share
$1.82
$1.50
Tangible Book Value
$193.74M
$26.74M
Working Capital
$197.27M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
-$51.86M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
-14.8%
-21.0%

Scores and fair valueIndustry

Altman Z-Score
18.02
0.26
Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodRLMDS&P 500DifferenceRLMD per yearS&P 500 per year
1 month+18.5%-2.7%+21.2 pts
3 months-11.9%-1.7%−10.1 pts
Year to date-13.9%+11.9%−25.8 pts
1 year+6.4%+12.0%−5.6 pts
3 years+43.4%+78.2%−34.7 pts+12.8%+21.2%
5 years-81.8%+73.2%−155.0 pts-28.9%+11.6%
10 years+15.6%+309.6%−294.1 pts+1.5%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

11M RLMD shares were sold short on Oct 30, 2026, down 11.0% from the previous report, or 10.51% of the shares available to trade. At recent volumes it would take 6.4 days to buy them back. Over the last 20 sessions, 47.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202610,839,074-11.0%1,703,6186.4
Oct 15, 202612,179,982-9.3%1,425,5988.5
Sep 30, 202613,424,126-7.2%1,033,66013.0
Sep 15, 202614,463,677+6.3%1,564,2499.3
Aug 31, 202613,602,542+5.5%768,19117.7
Aug 14, 202612,893,514-4.9%1,379,3439.3
Jul 31, 202613,563,773+4.4%1,741,9857.8
Jul 15, 202612,990,487+22.0%1,535,3398.5
Jun 30, 202610,647,441+75.7%3,471,3383.1
Jun 15, 20266,060,018+3.7%1,369,2034.4
May 29, 20265,841,074+6.4%961,5236.1
May 15, 20265,487,630+2.6%898,2316.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?